Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US rival Pfizer which called the move “reckless.”

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup